Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessUse of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study
There is an increasing interest for real-life data on drug use in many countries. Reimbursement authorities more and more request observational studies to assess the conditions of use of the products but also ...
-
Article
PS7 - 2. Glycemic control and all-cause mortality risk in type 1 diabetes patients: the EURODIAB Prospective Complications Study
Glycemic targets and the benefit of intensive glucose control are currently under debate as intensive glycemic control has been suggested to have negative effects on mortality risk in type 2 diabetes patients....